Long-Term Safety of Latanoprostene Bunod Ophthalmic Solution 0.024% in Japanese Subjects With OAG or OHT

Inclusion Criteria: * Subjects must have a diagnosis of open angle glaucoma (OAG) (including normal-tension glaucoma \[NTG\],pigmentary or pseudoexfoliative glaucoma), or ocular hypertension (OHT) in one or both eyes. * Subjects must meet the following IOP requirements at Visit 3 (Eligibility, Day 0\[after washout for the subjects already on treatment\]): mean/median IOP ≥15 mmHg and ≤36 mmHg at 10 AM in at least 1 eye; and IOP ≤36 mmHg in both eyes. * Subjects with a corrected Decimal visual acuity (VA) or a Best-Corrected Decimal Visual Acuity (BCVA) of 0.5 or better in both eyes. Exclusion Criteria: * Subjects who are unable to discontinue contact lens use during and for 15 minutes following instillation of study drug and during study visits. * Subjects who are unable to discontinue other eye drop medications such as artificial tears for 15 minutes prior to and 15 minutes after instillation of study drug. * Subjects with a central corneal thickness greater than 600 μm in either eye. * Subjects with any condition that prevents reliable applanation tonometry in either eye. * Subjects with advanced glaucoma with a mean deviation (MD) \< -12 dB, a history of split fixation, or a field loss threatening fixation in either eye. * Subjects with any condition that prevents clear visualization of the fundus. * Subjects who are monocular (fellow eye is absent). * Subjects with aphakia in either eye. * Subjects with an active corneal disease in either eye. * Subjects with severe dry eye in either eye. * Subjects with a history/diagnosis of a clinically significant or progressive retinal disease in either eye. * Subjects with very narrow angles and subjects with angle closure congenital, or secondary glaucoma, and subjects with history of angle closure in either eye. * Subjects with any intraocular infection or inflammation in either eye within 3 months prior to Visit 1 (Screening). * Subjects with a history of ocular laser surgery in either eye within the 3 months (90 days) prior to Visit 1 (Screening). * Subjects with a history of incisional ocular surgery or severe trauma in either eye within 3 months prior to Visit 1 (Screening).